Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 22 Similar Profiles
Therapeutics Medicine & Life Sciences
Nursing Medicine & Life Sciences
Nurses Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Anemia Medicine & Life Sciences
Depression Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1985 1992

BIOMEDICAL RESEARCH SUPPORT GRANT

Abraham, I. L., Morrision, E., Kiley, M., Krowchuk, H., Youngblut, J., Workman, L., Roberts, B. & Fitzpatrick, J.

National Institutes of Health

4/1/859/29/92

Project: Research projectBiomedical Research Support Grants

Nursing Research
Health
Research
Cardiac Rehabilitation

Research Output 1982 2017

Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)

Aapro, M., Bokemeyer, C., Ludwig, H., Gascón, P., Boccadoro, M., Denhaerynck, K., Gorray, M., Krendyukov, A., MacDonald, K. & Abraham, I. Mar 1 2017 In : Journal of Geriatric Oncology. 8, 2, p. 86-95 10 p.

Research output: Research - peer-reviewArticle

Biosimilar Pharmaceuticals
Chemotherapy-Induced Febrile Neutropenia
Neoplasms
Filgrastim
Drug Therapy

Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis

Eljaaly, K., Alshehri, S., Aljabri, A., Abraham, I., Al Mohajer, M., Kalil, A. C. & Nix, D. E. Jun 2 2017 In : BMC Infectious Diseases. 17, 1, 385

Research output: Research - peer-reviewArticle

Meta-Analysis
Pneumonia
Odds Ratio
Confidence Intervals
Bacteria
Biosimilar Pharmaceuticals
Chemotherapy-Induced Febrile Neutropenia
Costs and Cost Analysis
pegfilgrastim
Filgrastim
3 Citations
gemcitabine
Pancreatic Neoplasms
Cost-Benefit Analysis
130-nm albumin-bound paclitaxel
Costs and Cost Analysis
1 Citations

Economic Evaluations of First-Line Chemotherapy Regimens for Pancreatic Cancer: A Critical Review

Gharaibeh, M., Bootman, J. L., McBride, A., Martin, J. & Abraham, I. Jan 1 2017 In : PharmacoEconomics. 35, 1, p. 83-95 13 p.

Research output: Research - peer-reviewReview article

Pancreatic Neoplasms
Cost-Benefit Analysis
Economics
Drug Therapy
Therapeutics